Brandi Roach

966 total citations · 1 hit paper
10 papers, 703 citations indexed

About

Brandi Roach is a scholar working on Infectious Diseases, Molecular Biology and Surgery. According to data from OpenAlex, Brandi Roach has authored 10 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 5 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in Brandi Roach's work include Clostridium difficile and Clostridium perfringens research (10 papers), Gut microbiota and health (4 papers) and Gastrointestinal motility and disorders (3 papers). Brandi Roach is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (10 papers), Gut microbiota and health (4 papers) and Gastrointestinal motility and disorders (3 papers). Brandi Roach collaborates with scholars based in Canada, United States and United Kingdom. Brandi Roach's co-authors include Dina Kao, Karen Madsen, Huiping Xu, Thomas Louie, Karen J. Goodman, Paul L. Beck, Marisela Silva, Andrew L. Mason, Kevin P. Rioux and Juan Jovel and has published in prestigious journals such as JAMA, Gastroenterology and Hepatology.

In The Last Decade

Brandi Roach

9 papers receiving 689 citations

Hit Papers

Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Mi... 2017 2026 2020 2023 2017 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brandi Roach Canada 7 549 412 293 249 160 10 703
Mustafa Alani United States 6 370 0.7× 240 0.6× 261 0.9× 163 0.7× 153 1.0× 19 563
Simon D. McLaughlin United Kingdom 17 194 0.4× 238 0.6× 446 1.5× 276 1.1× 354 2.2× 52 899
Yao‐Wen Cheng United States 11 252 0.5× 122 0.3× 193 0.7× 132 0.5× 148 0.9× 26 459
Jon Reich United States 5 232 0.4× 162 0.4× 167 0.6× 98 0.4× 73 0.5× 7 364
Claudia Simonelli Italy 5 284 0.5× 161 0.4× 202 0.7× 100 0.4× 88 0.6× 9 430
Monika Widłak United Kingdom 7 364 0.7× 273 0.7× 208 0.7× 188 0.8× 186 1.2× 17 669
Krista M. Newman United States 4 418 0.8× 232 0.6× 273 0.9× 177 0.7× 126 0.8× 6 477
Victoria McCune United Kingdom 5 277 0.5× 195 0.5× 130 0.4× 122 0.5× 84 0.5× 5 345
Alaric Colville United Kingdom 3 244 0.4× 181 0.4× 129 0.4× 108 0.4× 80 0.5× 4 332
A Dupont United States 5 156 0.3× 74 0.2× 86 0.3× 96 0.4× 120 0.8× 11 295

Countries citing papers authored by Brandi Roach

Since Specialization
Citations

This map shows the geographic impact of Brandi Roach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandi Roach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandi Roach more than expected).

Fields of papers citing papers by Brandi Roach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandi Roach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandi Roach. The network helps show where Brandi Roach may publish in the future.

Co-authorship network of co-authors of Brandi Roach

This figure shows the co-authorship network connecting the top 25 collaborators of Brandi Roach. A scholar is included among the top collaborators of Brandi Roach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandi Roach. Brandi Roach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Monaghan, Tanya, Anna M. Seekatz, Nicholas O. Markham, et al.. (2021). Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Associates With Functional Alterations in Circulating microRNAs. Gastroenterology. 161(1). 255–270.e4. 31 indexed citations
2.
Kao, Dina, Karen Wong, Kyla Cochrane, et al.. (2021). The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial. ˜The œLancet. Gastroenterology & hepatology. 6(4). 282–291. 61 indexed citations
3.
Monaghan, Tanya, Maja Pučić‐Baković, Frano Vučković, et al.. (2019). Decreased Complexity of Serum N-glycan Structures Associates with Successful Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection. Gastroenterology. 157(6). 1676–1678.e3. 9 indexed citations
4.
Allegretti, Jessica R., Dina Kao, Emmalee Phelps, et al.. (2019). Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?. Digestive Diseases and Sciences. 64(6). 1668–1671. 23 indexed citations
5.
Allegretti, Jessica R., Monika Fischer, Huiping Xu, et al.. (2019). In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation. Gut Microbes. 11(1). 51–62. 32 indexed citations
7.
Fischer, Monika, Colleen Kelly, Emmalee Phelps, et al.. (2017). Quality of Bowel Preparation does not Affect Outcome of Fecal Microbiota Transplantation for the Therapy Clostridium Difficile Infection. Gastroenterology. 152(5). S1004–S1005. 2 indexed citations
8.
Kao, Dina, Brandi Roach, Marisela Silva, et al.. (2017). Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection. JAMA. 318(20). 1985–1985. 438 indexed citations breakdown →
9.
Kao, Dina, Brandi Roach, Heekuk Park, et al.. (2015). Fecal microbiota transplantation in the management of hepatic encephalopathy. Hepatology. 63(1). 339–340. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026